Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidi Goodarzi

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Journal of Biological Chemistry|April 3, 2007
Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2Kristen R Taylor, Kenshi Yamasaki, Katherine A Radek, et al.
Nature Medicine|April 3, 2002
Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic miceSiri Atma W Greeley, Makoto Katsumata, Liping Yu, et al.
Melanoma Research|April 6, 2011
Complete regression of subcutaneous and cutaneous metastatic melanoma with high-dose intralesional interleukin 2 in combination with topical imiquimod and retinoid creamMiki Shirakawa Garcia, Yoko Ono, Steve R Martinez, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Journal of Biological Chemistry|April 3, 2007
Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2Kristen R Taylor, Kenshi Yamasaki, Katherine A Radek, et al.
Nature Medicine|April 3, 2002
Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic miceSiri Atma W Greeley, Makoto Katsumata, Liping Yu, et al.
Melanoma Research|April 6, 2011
Complete regression of subcutaneous and cutaneous metastatic melanoma with high-dose intralesional interleukin 2 in combination with topical imiquimod and retinoid creamMiki Shirakawa Garcia, Yoko Ono, Steve R Martinez, et al.
Pageof 2